Get started
000

DONGSUN GPHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

002210 chart


Full chart

Key stats


Market capitalization
‪103.87 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−205 KRW
Net income (FY)
‪−2.07 B‬ KRW
Revenue (FY)
‪88.59 B‬ KRW
Shares float
‪15.17 M‬
Beta (1Y)
0.08

Employees


Employees (FY)
343
Change (1Y)
+10 +3.00%
Revenue / Employee (1Y)
‪198.37 K‬ KRW
Net income / Employee (1Y)
‪−4.64 K‬ KRW

About DONGSUN GPHARMACEUTICAL


Sector
Health Technology
CEO
Yang-Gu Lee
Headquarters
Seoul
Website
dongsung-pharm.co.kr
Founded
1957
ISIN
KR7002210003
FIGI
BBG000BGYFG3
Dongsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals. It operates through the Pharmaceutical and Cosmetic business divisions. Its products include general and special medicines such anti-rheumatic and anti-inflammatory analgesics, anti-inflammatory enzymes, cardiovascular system, gastrintestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dematologicals, antibiotics, antidiarreals, antifungals, oral hypoglycemic agents, hormones, and tranquillizers. The company was founded by Sun-Kyu Lee on November 25, 1957 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 002210 is 4,465 KRW — it has increased by 0.34% in the past 24 hours. Watch DONGSUN GPHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGSUN GPHARMACEUTICAL stocks are traded under the ticker 002210.
002210 stock has risen by 0.45% compared to the previous week, the month change is a −0.33% fall, over the last year DONGSUN GPHARMACEUTICAL has showed a −28.67% decrease.
002210 reached its all-time high on Sep 5, 2018 with the price of 49,300 KRW, and its all-time low was 760 KRW and was reached on Oct 28, 2008. View more price dynamics on 002210 chart.
See other stocks reaching their highest and lowest prices.
002210 stock is 1.36% volatile and has beta coefficient of 0.08. Track DONGSUN GPHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is DONGSUN GPHARMACEUTICAL there?
Today DONGSUN GPHARMACEUTICAL has the market capitalization of ‪102.10 B‬, it has increased by 0.68% over the last week.
Yes, you can track DONGSUN GPHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
002210 net income for the last quarter is ‪−1.46 B‬ KRW, while the quarter before that showed ‪−1.06 B‬ KRW of net income which accounts for −37.87% change. Track more DONGSUN GPHARMACEUTICAL financial stats to get the full picture.
No, 002210 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 343.00 employees. See our rating of the largest employees — is DONGSUN GPHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGSUN GPHARMACEUTICAL EBITDA is ‪−1.18 B‬ KRW, and current EBITDA margin is 2.98%. See more stats in DONGSUN GPHARMACEUTICAL financial statements.
Like other stocks, 002210 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGSUN GPHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DONGSUN GPHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DONGSUN GPHARMACEUTICAL stock shows the sell signal. See more of DONGSUN GPHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.